|
Volumn 64, Issue 4, 2001, Pages 427-434
|
Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: Monitoring of serum TUVIRUMAB in immune complexes
|
Author keywords
Anti HBs; Hepatitis B; Immunecomplexes; Monoclonal; Therapy; TUVIRUMAB
|
Indexed keywords
HEPATITIS B SURFACE ANTIGEN;
HUMAN MONOCLONAL ANTIBODY;
LAMIVUDINE;
TUVIRUMAB;
UNCLASSIFIED DRUG;
ANTIBODY TITER;
ANTIGEN EXPRESSION;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DOSE RESPONSE;
ENZYME IMMUNOASSAY;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
VIRUS NEUTRALIZATION;
ANTIBODIES, MONOCLONAL;
ANTIGEN-ANTIBODY COMPLEX;
COHORT STUDIES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HEPATITIS B ANTIBODIES;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B, CHRONIC;
HUMANS;
INJECTIONS, INTRAVENOUS;
LAMIVUDINE;
NEUTRALIZATION TESTS;
REVERSE TRANSCRIPTASE INHIBITORS;
|
EID: 0034968805
PISSN: 01466615
EISSN: None
Source Type: Journal
DOI: 10.1002/jmv.1068 Document Type: Article |
Times cited : (14)
|
References (11)
|